The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer
Unified Wilsons Disease Rating Scale a proposal for the neurological scoring of Wilsons disease patients
The concomitant use of topiramate with other carbonic anhydrase inhibitors or in patients on a ketogenic diet may create a physiological environment that increases the risk of kidney stone formation and should therefore be avoided
Research suggests that IGF-1 DES may have greater potency than IGF1 LR3 on a molar basis, possibly due to even lower IGFBP binding
SelfAssembled Fluorescent and Antibacterial GHKCu Nanoparticles for Wound Healing Applications
In some embodiments, the loss is caused by a brain injury, e.g